Axonal Damage in Multiple Sclerosis: Strategies for Protection and Repair

Document Type:	Grants Notice
Funding Opportunity Number:	PAS-05-002
Posted Date:	Oct 13, 2004
Original Due Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
Current Due Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
Archive Date:	Dec 02, 2007
Funding Instrument Type:	Grant
Category of Funding Activity:	Health
Expected Number of Awards:	Not Available.
Estimated Total Program Funding:	$1,500,000.00
Award Ceiling:	$200,000.00
Award Floor:	none
CFDA Number:	93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement:	No

Eligible Applicants

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

For profit organizations other than small businesses

Small businesses

Public and State controlled institutions of higher education

Private institutions of higher education

State governments

County governments

City or township governments

Special district governments

Independent school districts

Native American tribal governments (Federally recognized)

Public housing authorities/Indian housing authorities

Native American tribal organizations (other than Federally recognized tribal governments)

Others (see text field entitled "Additional Information on Eligibility" for clarification)

Additional Information on Eligibility:

Eligible agencies of the Federal Government are eligible to apply.
Foreign institutions are eligible to apply.

Agency Name

Description

This Program Announcement with set-aside funds (PAS) invites applications proposing clinical and translational research in multiple sclerosis (MS) and targeting the neurodegenerative aspect of this disease. It is not intended to solicit proposals in basic neuroscience or glial biology. Rather, applications responsive to this PAS will apply ideas, insights, and discoveries generated through basic scientific inquiry to the treatment of MS and will have an emphasis on activities directly focused on the development of neuroprotective and regenerative therapies for MS. Applications testing novel therapeutic interventions in animal models or in in vitro systems are encouraged as are applications for the development of technologies that would facilitate the monitoring of their efficacy. Clinical trials and interventions in MS patients are not covered by this PAS and applicants are directed to instead use the funding mechanisms and opportunities listed at http!
://www.ninds.nih.gov/funding/clinical_trials/index.htm.

Link to Full Announcement

http://grants.nih.gov/grants/guide/pa-files/PAS-05-002.html

If you have difficulty accessing the full announcement electronically, please contact:

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster NIH OER Webmaster

• HHS NIH listed by [Posted Date]
• HHS Agencywide listed by [Posted Date]